166 related articles for article (PubMed ID: 37887557)
21. Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.
Ozaki S; Vuyyuru R; Kageyama K; Terai M; Ohara M; Cheng H; Manser T; Mastrangelo MJ; Aplin AE; Sato T
Am J Pathol; 2016 Jan; 186(1):43-56. PubMed ID: 26613897
[TBL] [Abstract][Full Text] [Related]
22. Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.
Nicolle D; Fabre M; Simon-Coma M; Gorse A; Kappler R; Nonell L; Mallo M; Haidar H; Déas O; Mussini C; Guettier C; Redon MJ; Brugières L; Ghigna MR; Fadel E; Galmiche-Rolland L; Chardot C; Judde JG; Armengol C; Branchereau S; Cairo S
Hepatology; 2016 Oct; 64(4):1121-35. PubMed ID: 27115099
[TBL] [Abstract][Full Text] [Related]
23. Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity.
Brown KM; Xue A; Julovi SM; Gill AJ; Pavlakis N; Samra JS; Smith RC; Hugh TJ
J Surg Res; 2018 Jul; 227():158-167. PubMed ID: 29804848
[TBL] [Abstract][Full Text] [Related]
24. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
25. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
Hao C; Wang L; Peng S; Cao M; Li H; Hu J; Huang X; Liu W; Zhang H; Wu S; Pataer A; Heymach JV; Eterovic AK; Zhang Q; Shaw KR; Chen K; Futreal A; Wang M; Hofstetter W; Mehran R; Rice D; Roth JA; Sepesi B; Swisher SG; Vaporciyan A; Walsh GL; Johnson FM; Fang B
Cancer Lett; 2015 Feb; 357(1):179-185. PubMed ID: 25444907
[TBL] [Abstract][Full Text] [Related]
26. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract][Full Text] [Related]
27. Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.
Abdel-Rahman MH; Cebulla CM; Verma V; Christopher BN; Carson WE; Olencki T; Davidorf FH
Exp Eye Res; 2012 Jul; 100():26-31. PubMed ID: 22569040
[TBL] [Abstract][Full Text] [Related]
28. Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation.
Serra-Camprubí Q; Verdaguer H; Oliveros W; Lupión-Garcia N; Llop-Guevara A; Molina C; Vila-Casadesús M; Turpin A; Neuzillet C; Frigola J; Querol J; Yáñez-Bartolomé M; Castet F; Fabregat-Franco C; Escudero-Iriarte C; Escorihuela M; Arenas EJ; Bernadó-Morales C; Haro N; Giles FJ; Pozo ÓJ; Miquel JM; Nuciforo PG; Vivancos A; Melé M; Serra V; Arribas J; Tabernero J; Peiró S; Macarulla T; Tian TV
Clin Cancer Res; 2023 Jan; 29(2):432-445. PubMed ID: 36374558
[TBL] [Abstract][Full Text] [Related]
29. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
Yavuzyigitoglu S; Koopmans AE; Verdijk RM; Vaarwater J; Eussen B; van Bodegom A; Paridaens D; Kiliç E; de Klein A;
Ophthalmology; 2016 May; 123(5):1118-28. PubMed ID: 26923342
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal rearrangements in uveal melanoma: Chromothripsis.
van Poppelen NM; Yavuzyigitoglu S; Smit KN; Vaarwater J; Eussen B; Brands T; Paridaens D; Kiliç E; de Klein A
Genes Chromosomes Cancer; 2018 Sep; 57(9):452-458. PubMed ID: 29726589
[TBL] [Abstract][Full Text] [Related]
31. Uveal melanoma: physiopathology and new in situ-specific therapies.
Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
[TBL] [Abstract][Full Text] [Related]
32. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
33. Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs).
Patel KR; Espinoza AF; Urbicain M; Patel RH; Major A; Sarabia SF; Lopez-Terrada D; Vasudevan SA; Woodfield SE
Pathol Res Pract; 2024 Mar; 255():155163. PubMed ID: 38394806
[TBL] [Abstract][Full Text] [Related]
34. Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma.
Carita G; Frisch-Dit-Leitz E; Dahmani A; Raymondie C; Cassoux N; Piperno-Neumann S; Némati F; Laurent C; De Koning L; Halilovic E; Jeay S; Wylie A; Emery C; Roman-Roman S; Schoumacher M; Decaudin D
Oncotarget; 2016 Jun; 7(23):33542-56. PubMed ID: 27507190
[TBL] [Abstract][Full Text] [Related]
35. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
[TBL] [Abstract][Full Text] [Related]
36. Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071.
Piperno-Neumann S; Larkin J; Carvajal RD; Luke JJ; Schwartz GK; Hodi FS; Sablin MP; Shoushtari AN; Szpakowski S; Chowdhury NR; Brannon AR; Ramkumar T; de Koning L; Derti A; Emery C; Yerramilli-Rao P; Kapiteijn E
Mol Cancer Ther; 2020 Apr; 19(4):1031-1039. PubMed ID: 32029634
[TBL] [Abstract][Full Text] [Related]
37. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.
Braekeveldt N; Wigerup C; Gisselsson D; Mohlin S; Merselius M; Beckman S; Jonson T; Börjesson A; Backman T; Tadeo I; Berbegall AP; Ora I; Navarro S; Noguera R; Påhlman S; Bexell D
Int J Cancer; 2015 Mar; 136(5):E252-61. PubMed ID: 25220031
[TBL] [Abstract][Full Text] [Related]
38. Uveal Melanoma Patient-Derived Xenografts.
Carita G; Némati F; Decaudin D
Ocul Oncol Pathol; 2015 Apr; 1(3):161-9. PubMed ID: 27172261
[TBL] [Abstract][Full Text] [Related]
39. Cancer "Avatars": Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer.
Lynch IT; Abdelrahman AM; Alva-Ruiz R; Fogliati A; Graham RP; Smoot R; Truty MJ
J Am Coll Surg; 2023 Sep; 237(3):483-500. PubMed ID: 37326316
[TBL] [Abstract][Full Text] [Related]
40. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
